Steven Smith
Giving Up Gains but Gaining a Cushion
A beneficial tradeoff of limiting your profit potential is that shorting calls can substantially raise your net sales price. In our example, the effective sale price is $55.80, $5.80 or 11.6% higher than the current market price of $50. "One of the major misconceptions involved in selling naked options is the risk, when in fact it is no greater than being outright short the underlying," says Mike Schwartz, chief option strategist at Fahnestock's Oppenheimer division. Schwartz's statement echoes a general rule of thumb in options trading: Don't be naked options with more than 90 days remaining until expiration. "This allows one to take advantage of the fact that options are an eroding asset," he says. An option's time decay, as defined by theta, accelerates as the expiration date approaches.Winning by Not Losing
This means that even if the shares of the underlying simply stall or rise slowly, the naked-call seller can still realize a maximum profit. The table below provides the profit and loss profile for our hypothetical example.| Shorting 500 Shares of XYZ at $50 vs. Shorting 5 July $55 calls P/L Based on price of XYZ on July 18 expiration |
||||
| Position | $45 | $50 | $55 | $60 |
| Short 500 XYZ at $50 | $2,500 | 0 | ($2500) | ($5000) |
| Short five XYZ July $55 calls at 80 cents each | $400 | $400 | $400 | ($4600) |
Shorting Biotech
While shorting biotechnology stocks has proven hazardous to your portfolio's health recently, I think this group is a prime candidate for employing a short call strategy. Using the Biotech HOLDRs(BBH) Exchange Traded Fund, or ETF, as a proxy for the group, the sector has gained some 38% over the past three months.| BBH Has Had Healthy Run But now it needs to rest? |
If you're new to RealMoney, we hope you're enjoying our open house. If you're interested in sampling our premium content for a little longer, click here for information on a free trial.
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,419.86 | 1,313.32 | 2,837.36 | 16.25 |
Oil *
103.00
|
|
DOWN
160.83 |
DOWN
19.10 |
DOWN
33.63 |
DOWN
1.06 |
10 Yr
1.62%
SPDR Gold
151.91
|
|
-1.28%
|
-1.43%
|
-1.17%
|
-6.12%
|
Data delayed 20 minutes |


Connect with TheStreet